Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
07/2001
07/05/2001US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture
07/05/2001CA2393583A1 Compounds active at the glucocorticoid receptor
07/04/2001EP1113000A1 Benzene derivatives and medicinal use thereof
07/04/2001CN1302289A Process for preparing phenylalkanoic acid amides and intermediates therefor
07/03/2001US6255528 Reacting an alkylfluorobromobenzene or fluorobromobenzene with acrylamide in presence of palladium catalyst, hydrogenating the resulting arylacrylamide, and then rearranging it
07/03/2001US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
07/03/2001US6255342 Pesticides
07/03/2001US6255326 Antiinflammatory agent; autoimmune diseases
06/2001
06/28/2001WO2001046125A2 Cd45 inhibitors
06/27/2001EP1109805A1 Inhibitors of bacterial nad synthetase
06/27/2001EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides
06/27/2001CN1301154A Amide derivatives and nociceptin antagonists
06/27/2001CN1067550C Calcium receptor active molecules
06/26/2001US6252104 3,6-disubstituted-2-oxynaphthalene derivatives; raw materials for synthesis of such materials as dyes, pigments, photosensitive materials
06/26/2001US6252078 Fungicides for the control of take-all disease of plants
06/26/2001US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/21/2001WO2001044199A1 Compounds and compositions for delivering active agents
06/21/2001WO2001044170A1 Adamantane derivatives
06/20/2001EP1107997A2 Polymer production
06/20/2001CN1300279A Modulators of protein tyrosine phosphatases
06/20/2001CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines
06/20/2001CN1299811A Alpha-alkylacyl-beta-substituted benzoyl-beta-phenylpropionyl aniline and its synthesis and use
06/19/2001US6248894 Fungicides for the control of take-all disease of plants
06/19/2001US6248743 Antithrombotic agents effective to inhibit the production of type 1 plasminogen activator inhibitor (pai-1)
06/14/2001WO2001042194A1 Adamantane derivatives
06/14/2001CA2394236A1 Adamantane derivatives
06/13/2001EP1105359A1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
06/12/2001US6245810 Amino acid derivatives
06/12/2001US6245804 Contraceptives; urogenital disorders
06/12/2001US6245786 Substituted aryl or heteroarylamides having retinoid-like biological activity
06/12/2001US6245359 Active agent transport systems
06/07/2001WO2001040188A1 Curcumin analogues for treating cancer
06/07/2001US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant
06/07/2001US20010003001 Compounds and compositions for delivering active agents
06/07/2001CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties
06/06/2001CN1297885A Preparation of 1.1-cyclohexyl oxalic amide
06/05/2001US6242615 Amidation of acid containing compounds; useful in inhibiting tumor necrosis factor and metalloproteinases
06/05/2001US6242609 Ammonium trihalide for halogenation of color couplers and silver halide emulsions
06/05/2001US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid
06/05/2001US6242495 Compounds and compositions for delivering active agents
06/05/2001US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents
06/05/2001US6242480 Ophthalmic viscoelastic compositions
06/05/2001US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation
05/2001
05/31/2001WO2001038294A2 Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives
05/31/2001WO2001038292A2 Method for producing optically active amines
05/31/2001WO1999024394A9 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
05/31/2001DE19956920A1 Production of 2-(2-hydroxyphenyl)-2-alkoxyimino-N-methylacetamide compounds, useful as intermediates for fungicides, via new intermediates
05/31/2001DE19956786A1 New optically active aminoalcohol and diamine derivatives useful as intermediates, e.g. for pharmaceuticals and plant protectants
05/30/2001EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines
05/30/2001EP1102743A1 Amide derivatives which are useful as cytokine inhibitors
05/30/2001EP1102742A2 Compounds and compositions for delivering active agents
05/30/2001EP1102739A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
05/30/2001CN1066452C Crystalline cephem acid addition salts and processes for their preparation
05/29/2001US6239297 Sphingosine derivatives and medicinal composition
05/29/2001US6238655 α-amides of L-amino acid as fragrance precursors
05/29/2001US6238649 Cosmetic and pharmaceutical preparations containing photostable UV filters
05/25/2001WO2001036376A1 Novel phenylalanine derivatives
05/25/2001WO2001035955A1 Benzene derivatives and use thereof as drugs
05/23/2001EP1101755A1 Anthranilic acid derivatives
05/23/2001EP1100853A2 Adhesives and sealants
05/23/2001EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
05/23/2001EP1100771A1 Compounds and compositions for delivering active agents
05/23/2001EP1100770A2 Monomers and network polymers obtained therefrom
05/23/2001EP1100522A1 Pulmonary delivery of active agents
05/23/2001EP1100495A1 Propenamides as ccr5 modulators
05/23/2001EP1100486A1 Macrophage scavenger receptor antagonists
05/23/2001EP1100485A1 Substituted anilide compounds and methods
05/23/2001EP1100332A1 Herbicidal phenoxypropionic acid n-alkyl-n-2-fluorophenyl amide compounds
05/23/2001EP0929535A4 Process and novel intermediates
05/22/2001US6235875 Human and animal anthelmintic
05/22/2001US6235789 Glandular disorders; sleep disorders
05/22/2001US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide
05/16/2001EP0798288B1 Triciclic compounds
05/15/2001US6232342 Protease inhibitors
05/15/2001US6232057 Achieving enhanced sensitivity and reduced fog using iodide ion releasing compound which can release the iodide ion rapidly.
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/10/2001WO2001032604A1 Activators of soluble guanylate cyclase
05/10/2001WO2001032596A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents
05/10/2001WO2001032130A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
05/10/2001CA2390025A1 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
05/10/2001CA2389773A1 Activators of soluble guanylate cyclase
05/09/2001EP1097158A2 Ligands for metals and metal-catalyzed processes
05/09/2001EP1097137A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
05/09/2001EP1097129A1 N-benzocycloalkyl-amide derivatives and their use as medicaments
05/09/2001EP1097117A2 Aryl vinyl ether derivatives and their use as herbicides
05/09/2001CN1065559C Photo-cross-linkable optically active compounds
05/08/2001US6229026 Reacting an isobenzofuran derivative with grignard reagents 4-halogen-fluorophenyl and 3-halogen-n,n-dimethylpropylamine; causing ring-closure of the product and conversion to 5-cyano derivative
05/08/2001US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors
05/03/2001WO2001030736A2 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
05/02/2001EP1095932A1 Phenoxyacetic acid derivatives and medicinal compositions containing the same
05/02/2001EP1095930A1 Novel compounds
05/02/2001EP1095109A1 Powder paint binder composition
05/02/2001EP1094812A1 Angiogenesis inhibitors
05/02/2001EP0920409B1 A process for the production of a condensation product of a carboxylic acid
05/02/2001EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
05/02/2001CN1293656A Anti-tumour agents
05/01/2001USRE37160 Synthesis of tyrosine derived diphenol monomers
05/01/2001US6225375 Preparation of low-dust stabilizers
05/01/2001US6225352 Low molecular weight dendritic compounds as pharmaceutical agents
05/01/2001US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids)
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 157